Outline

JEIM

Mechanistic Investigation of Human Placental Extract Fractions on the Erythrocyte Membrane–Cytoskeleton System

Author(s): Oleg Nardid1, Svetlana Repina1, Ekaterina Rozanova1, Yana Cherkashina1, Andriy Mykhailovych Serdyuk2
1Department of Cryobiophysics, Institute for Problems of Cryobiology and Cryomedicine, National Academy of Sciences of Ukraine.
2State Institution Marzieiev Institute for Public Health of the National Academy of Medical Sciences of Ukraine.
[mla_citation]

Abstract

Human placental extracts (HPE) contain a wide spectrum of biologically active molecules
including peptides, growth factors, and immunomodulatory proteins. Previous studies
indicate that storage conditions influence the biological properties of these extracts and
their interaction with erythrocytes. However, the molecular mechanisms underlying these
interactions remain poorly understood. The present study investigates the mechanistic
interaction between placental extract fractions and the erythrocyte membrane–cytoskeleton
system. Fractionated placental extracts were analyzed for their influence on erythrocyte
membrane stability, cytoskeleton organization, and cytosolic microviscosity. Biophysical
measurements including hemolysis assays, osmotic fragility tests, and electron paramagnetic resonance (EPR) spectroscopy were conducted. The findings demonstrate that specific low molecular weight fractions significantly alter erythrocyte membrane protein interactions, particularly those associated with the Band-3 protein complex. These changes are accompanied by modifications in cytosol microviscosity and membrane stability. The results provide new insights into the cellular mechanisms of placental extract activity and may contribute to the development of therapeutic applications in regenerative medicine and cryobiology.

Keywords
Human placental extract, erythrocyte membrane, membrane–cytoskeleton interaction, Band-3 protein, osmotic fragility, hemolysis, cytosol microviscosity, electron paramagnetic resonance, placental bioactive fractions, cryobiology.

Related Articles

Azra Nishat1, Shazadi Sultana2, Arshiya Sultana2
1Department of Obstetrics and Gynecology, Government Nizamia Tibbi College Charminar, Hyderabad, India
2Department of Obstetrics and Gynecology, National Institute of Unani Medicine, PG Institute of Research, Bengaluru, Karnataka, India.
Rinaldo Bellomo1,2, John A. Kellum3, Claudio Ronco4
1Department of Intensive Care, Austin Hospital, Melbourne, Australia
2School of Medicine, The University of Melbourne, Australia
3Center for Critical Care Nephrology, University of Pittsburgh, USA.
4International Renal Research Institute, Vicenza, Italy.
Ivica Letunic1, Lars Nielsen1, Peer Bork2,3
1Biobyte solutions GmbH, Bothestr 142, 69126 Heidelberg, German
2EMBL, Meyerhofstrasse 1, 69117 Heidelberg, Germany.
3Department of Bioinformatics, Biocenter, University of Würzburg, Würzburg, Germany.
Michael Henderson1, Carol Inatsuka2, Amanda J. Sheets1, Corinne L. Williams3, David J. Benaron2, Gina M. Donato4, Mary C. Gray4, Erik L. Hewlett4, Peggy A. Cotter1,3
1Department of Microbiology and Immunology, School of Medicine, University of North Carolina at Chapel Hill, USA.
2Department of Molecular, Cellular and Developmental Biology, University of California, Santa Barbara, USA.
3Department of Molecular, Cellular and Developmental Biology, University of California, Santa Barbara, USA
4Division of Infectious Diseases and International Health, Department of Medicine, University of Virginia School of Medicine, USA
Eisha Nisar1, Rong Chen2, Atul Janardhan Butte2
1Faisalabad Medical University, faisalabad, Pakistan.
2Lucile Packard Children’s Hospital, Palo Alto, California, USA.
Olusola Ayanniyi1, Olusoji G. Ige2
1Department of Physiotherapy, College of Medicine, University of Ibadan, Ibadan, Nigeria.
2Physiotherapy Department, College of Medicine, University of Ibadan/UCH, Ibadan, Nigeria.